Revolution Biomanufacturing, Inc.
US-based contract biomanufacturer focused on mRNA and nucleic acid manufacturing for personalized medicine. Offers end-to-end services including mRNA synthesis, template production, LNP formulation, protein fermentation/purification, and cGMP fill-finish. Provides regulatory strategy and outsourced project management to support IND/BLA/NDA pathways and commercialization.
Industries
N/A
Services
Process Development
Custom UTR/codon design, DNA template engineering, IVT optimization, downstream process development, and cell line development to support mRNA and biologics production.
LNP Formulation
Development and engineering of lipid nanoparticle encapsulation systems and formulation strategies for nucleic acid delivery.
cGMP Manufacturing
GMP-compliant manufacturing of mRNA drug substance, LNP formulation, fill–finish, and final product release operations in a US-based facility.
Regulatory Strategy & Project Management
Regulatory guidance for IND/BLA/NDA submissions, gap assessments, and outsourced project management to align stakeholders and timelines.
Process Development
Custom UTR/codon design, DNA template engineering, IVT optimization, downstream process development, and cell line development to support mRNA and biologics production.
LNP Formulation
Development and engineering of lipid nanoparticle encapsulation systems and formulation strategies for nucleic acid delivery.
cGMP Manufacturing
GMP-compliant manufacturing of mRNA drug substance, LNP formulation, fill–finish, and final product release operations in a US-based facility.
Regulatory Strategy & Project Management
Regulatory guidance for IND/BLA/NDA submissions, gap assessments, and outsourced project management to align stakeholders and timelines.
Expertise Areas
- mRNA manufacturing
- Personalized medicine manufacturing
- Process development for nucleic acids
- LNP formulation and delivery
Key Technologies
- mRNA in vitro transcription (IVT)
- UTR and codon optimization
- DNA template engineering
- Lipid nanoparticle (LNP) formulation